Literature DB >> 12402168

Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection: evidence for activation of innate immunity and neuronal injury.

J B Johnston1, C Silva, T Hiebert, R Buist, M R Dawood, J Peeling, C Power.   

Abstract

Lentiruses cause neurological disease depending on the virus strain and its neurotropism, yet it remains uncertain to what the impact of infectious virus quantity in the brain early in infection is on the subsequent development of neurological disease or neurovirulence. We investigated the relationship between infectious virus input titer and the resulting neurovirulence, using ex vivo and in vivo assays of feline immunodeficiency virus (FIV)-induced neurovirulence. FIV infection of cell cultures and neonatal cats was performed using 10(2.5) (low-titer) or 10(4.5) (high-titer) 50% tissue culture infectious doses (TCID(50))/ml of the neurovirulent FIV strain, V1CSF. Ex vivo neurotoxicity assays revealed that conditioned medium (CM) from feline macrophages infected with high-titer (P <.001) or low-titer (P <.01) V1CSF induced greater neuronal death than CM from mock-infected cells. In vivo, animals infected intracranially with high-titer V1CSF showed neurodevelopmental delays compared to mock-infected animals (P <.001) and animals infected with low-titer V1CSF (P <.02), concurrent with reduced weight gains and greater depletion of CD4+ cells over a 12-week period. Neuropathological changes, including astrogliosis, macrophage activation, and neuronal damage, were evident in V1CSF-infected animals and were viral titer dependent. In vivo magnetic resonance (MR) spectroscopy and proton nuclear magnetic resonance ((1)H-NMR) spectroscopy of tissue extracts revealed evidence of neuronal injury, including reduced N-acetyl aspartate/creatine (P <.05) and increased trimethylamine/creatine (P <.05) ratios, in the frontal cortex of high-titer V1CSF-infected animals compared to the other groups. T2-weighted MR imaging detected increased signal intensities in the frontal cortex and white matter of V1CSF-infected animals relative to controls, which was more evident as viral titer increased (P <.01). The present findings indicate that lentivirus infectious titers in the brain during the early stages of infection determine the severity of neurovirulence, reflected by neurobehavioral deficits, together with neuroradiological and neuropathological findings of activation of innate immunity and neuronal injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402168     DOI: 10.1080/13550280260422721

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  47 in total

1.  Temporal profile of magnetic resonance imaging changes following forebrain ischemia in the gerbil.

Authors:  H Lei; P Dooley; J Peeling; D Corbett
Journal:  Neurosci Lett       Date:  1998-11-27       Impact factor: 3.046

Review 2.  NMR spectroscopy of brain metabolism in vivo.

Authors:  J W Prichard; R G Shulman
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

Review 3.  Immunopathogenesis of HIV-associated dementia.

Authors:  S L Wesselingh; K A Thompson
Journal:  Curr Opin Neurol       Date:  2001-06       Impact factor: 5.710

4.  Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus.

Authors:  A Poli; M Pistello; M A Carli; F Abramo; G Mancuso; E Nicoletti; M Bendinelli
Journal:  J Neurovirol       Date:  1999-10       Impact factor: 2.643

Review 5.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

6.  Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

Authors:  J Johnston; C Power
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Neurological abnormalities associated with feline immunodeficiency virus infection.

Authors:  T R Phillips; O Prospero-Garcia; D L Puaoi; D L Lerner; H S Fox; R A Olmsted; F E Bloom; S J Henriksen; J H Elder
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891

8.  Neurotoxicity of FIV and FIV envelope protein in feline cortical cultures.

Authors:  D C Bragg; R B Meeker; B A Duff; R V English; M B Tompkins
Journal:  Brain Res       Date:  1999-01-23       Impact factor: 3.252

9.  Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging.

Authors:  D J Meyerhoff; S MacKay; L Bachman; N Poole; W P Dillon; M W Weiner; G Fein
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

10.  Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression.

Authors:  C Power; R Buist; J B Johnston; M R Del Bigio; W Ni; M R Dawood; J Peeling
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more
  9 in total

1.  Suppression of immunodeficiency virus-associated neural damage by the p75 neurotrophin receptor ligand, LM11A-31, in an in vitro feline model.

Authors:  Rick B Meeker; Winona Poulton; Wen-hai Feng; Lola Hudson; Frank M Longo
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-10       Impact factor: 4.147

2.  Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress.

Authors:  Ferdinand Maingat; Brendan Halloran; Shaona Acharjee; Guido van Marle; Deirdre Church; M John Gill; Richard R E Uwiera; Eric A Cohen; Jon Meddings; Karen Madsen; Christopher Power
Journal:  FASEB J       Date:  2011-03-22       Impact factor: 5.191

Review 3.  Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

Authors:  Guido van Marle; Christopher Power
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

Review 4.  The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome.

Authors:  Nicola F Fletcher; Rick B Meeker; Lola C Hudson; John J Callanan
Journal:  Vet J       Date:  2010-04-24       Impact factor: 2.688

5.  Correlating magnetic resonance findings with neuropathology and clinical signs in dogs and cats.

Authors:  Charles H Vite; Johnny R Cross
Journal:  Vet Radiol Ultrasound       Date:  2011 Mar-Apr       Impact factor: 1.363

6.  In vivo CXCR4 expression, lymphoid cell phenotype, and feline immunodeficiency virus infection.

Authors:  Sean P Troth; Alan D Dean; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

7.  Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence.

Authors:  Amir Afkhami-Goli; Shu-Hong Liu; Yu Zhu; Joseph M Antony; Hosseinali Arab; Christopher Power
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

Review 8.  Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

Authors:  Christopher Power
Journal:  J Neurovirol       Date:  2017-12-15       Impact factor: 2.643

Review 9.  Comparative neurovirulence in lentiviral infections: The roles of viral molecular diversity and select proteases.

Authors:  Christopher Power; Kunyan Zhang; Guido van Marle
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.